Contrast nephropathy after coronary angiography.
D000111:Acetylcysteine / Q000627:therapeutic use; D003287:Contrast Media / Q000009:adverse effects*; D017023:Coronary Angiography; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D007552:Isotonic Solutions; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D009994:Osmolar Concentration; D012307:Risk Factors; D012965:Sodium Chloride / Q000627:therapeutic use
D003287:Contrast Media; D016166:Free Radical Scavengers; D007552:Isotonic Solutions; D012965:Sodium Chloride; D000111:Acetylcysteine